Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Details 3)

v3.23.2
Summary of Significant Accounting Policies (Details 3) - shares
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total common stock equivalents 2,809,400 2,725,436 2,809,400 2,725,436
Options Held [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total common stock equivalents 393,540 306,243 393,540 306,243
Warrant [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total common stock equivalents 2,415,860 2,419,193 2,415,860 2,419,193